OJIAJE EHIMEN: Open Payments
NPI 1730763582 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 40 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $40 · 2025 $1,138
Food & beverage: $1,138
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $407 |
| Otsuka America Pharmaceutical, Inc. | 7 | $203 |
| Janssen Pharmaceuticals, Inc | 5 | $160 |
| ABBVIE INC. | 4 | $78 |
| Neurocrine BioSciences, Inc. | 2 | $64 |
| Vanda Pharmaceuticals Inc. | 2 | $59 |
| Lundbeck LLC | 2 | $43 |
| Tris Pharma Inc | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Auvelity, REXULTI, SPRAVATO, VRAYLAR, INGREZZA, HETLIOZ, Onyda XR, TRINTELLIX.
Industry payments across GA — which companies pay providers there.
